Angelini Ventures
Angelini Ventures leads €10M investment in digital health startup Vantis to transform chronic disease management
Angelini Ventures has led a €10 million Series A financing round in Vantis, a Munich-based company transforming primary care through digital innovation.
This strategic investment addresses critical challenges in European healthcare systems, including GP shortages and the growing burden of chronic disease management. These figures are consistent with the scenario across Europe, where a shortage of healthcare professionals is estimated by the WHO to reach approximately 4 million by 2030 (including 600,000 doctors).
In this context, Angelini Ventures' investment in Vantis aligns with a broader strategy aimed at identifying hybrid care platform solutions that will be crucial for managing the doctor-patient relationship in the future.
Vantis combines technology-driven efficiency with optimized practice management to deliver more personalized, data-driven care for patients with chronic conditions. Bayern Kapital, Twip Impact Ventures, and existing investors firstminute and b2venture also participated in this funding round, which will enable Vantis to enhance its use of telemedicine, continuous monitoring, digital therapies, and AI-powered processes.
Vantis is redefining primary care by combining digital innovation with hands-on clinical expertise. Its approach not only streamlines practice operations but also enables physicians to deliver more personalized and data-driven care, particularly for patients with chronic conditions. This aligns with our commitment to supporting companies that bring tangible, technology-enabled improvements to healthcare.
Nils Bottler,
The funding will enable Vantis to continue developing its data-driven, proactive approach to chronic disease management, as well as to expand its team and enhance its use of telemedicine, continuous monitoring, digital therapies, and AI-powered processes.